ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 22 filers reported holding ENOCHIAN BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $597,701 | +2175.4% | 133,714 | +188.4% | 0.00% | – |
Q2 2023 | $26,268 | -62.0% | 46,361 | -38.7% | 0.00% | – |
Q1 2023 | $69,213 | -5.8% | 75,634 | +6.0% | 0.00% | – |
Q4 2022 | $73,480 | -72.7% | 71,340 | -52.1% | 0.00% | – |
Q3 2022 | $269,000 | +7.6% | 148,908 | +14.9% | 0.00% | – |
Q2 2022 | $250,000 | -42.8% | 129,618 | +144.9% | 0.00% | – |
Q1 2022 | $437,000 | -56.0% | 52,935 | -61.1% | 0.00% | – |
Q4 2021 | $994,000 | +8.0% | 136,242 | -0.4% | 0.00% | – |
Q3 2021 | $920,000 | +889.2% | 136,729 | +620.1% | 0.00% | – |
Q2 2021 | $93,000 | +38.8% | 18,987 | -0.8% | 0.00% | – |
Q1 2021 | $67,000 | -22.1% | 19,133 | -34.1% | 0.00% | – |
Q4 2020 | $86,000 | +1333.3% | 29,013 | +1465.7% | 0.00% | – |
Q3 2020 | $6,000 | -71.4% | 1,853 | -61.9% | 0.00% | – |
Q2 2020 | $21,000 | +250.0% | 4,861 | +163.8% | 0.00% | – |
Q1 2020 | $6,000 | -93.8% | 1,843 | -90.3% | 0.00% | – |
Q4 2019 | $96,000 | +966.7% | 19,081 | +1005.5% | 0.00% | – |
Q3 2019 | $9,000 | +200.0% | 1,726 | +151.6% | 0.00% | – |
Q2 2019 | $3,000 | -88.5% | 686 | -81.7% | 0.00% | – |
Q1 2019 | $26,000 | – | 3,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 79,314 | $534,000 | 0.07% |
Dorsey Wright & Associates | 7,869 | $53,000 | 0.01% |
Jacobi Capital Management LLC | 6,650 | $45,000 | 0.01% |
Cubist Systematic Strategies, LLC | 31,314 | $211,000 | 0.00% |
UNITED CAPITAL FINANCIAL ADVISORS, LLC | 71,291 | $480,000 | 0.00% |
ETF MANAGERS GROUP, LLC | 18,848 | $126,000 | 0.00% |
TRUIST FINANCIAL CORP | 78,444 | $528,000 | 0.00% |
UBS Group AG | 15 | $0 | 0.00% |
FIRST TRUST ADVISORS LP | 21,420 | $144,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 144 | $969,000 | 0.00% |